salesforce(US:CRM) 智通财经网·2026-02-26 16:17Core Viewpoint - Salesforce (CRM.US) continues to demonstrate double-digit growth in its latest earnings report, with a focus on the commercialization progress of its flagship AI product, Agentforce. However, several Wall Street investment banks remain cautious about whether the overall revenue growth can significantly rebound [1][2]. Group 1: Financial Performance - Salesforce's fourth-quarter performance shows robust growth, with Agentforce's annual recurring revenue (ARR) reaching $800 million, a 169% year-over-year increase [1]. - Data 360's ARR has grown to $1 billion, and Agentforce's quarterly transaction volume exceeded 29,000, reflecting a 50% quarter-over-quarter increase [1]. - Over 60% of orders for Agentforce and Data 360 come from existing customers, indicating a deepening customer engagement [1]. Group 2: Analyst Ratings and Price Targets - Morgan Stanley maintains an "Overweight" rating with a target price of $287, noting that the product cycle of Agentforce alone may not significantly enhance market valuation [2]. - JPMorgan also holds an "Overweight" rating but has lowered its target price from $365 to $320, highlighting a shift towards a consumption-based model with Flex Credits [2]. - Wells Fargo adopts a "Neutral" rating with a target price reduction to $210, citing that the highlights from Agentforce are overshadowed by overall underperformance [3]. Group 3: Strategic Initiatives - Salesforce announced a new $50 billion stock buyback plan, replacing all previously unused authorizations, which supports long-term growth objectives [3]. - The company reiterated its goal to achieve a revenue growth rebound in the second half of fiscal year 2027, providing a foundation for future growth [2].